Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Bullboard Posts
Comment by Benedictuson Aug 30, 2019 6:11am
114 Views
Post# 30082204

RE:RE:RE:RE:RE:Midus letter

RE:RE:RE:RE:RE:Midus letterkyle, you bring up some fair points but promotion is just part of the game right alongside marketing and branding imo. These guys are good at it and I like that.

The burn rate is somewhat of a concern but with 50M cash on hand, when they do need to do a raise, next year, their annual run rate should be in the vicinity of 50M + according to Chris. That's a forward psr of about 3.5 based on today's mkt cap.

the kuida cosmeceutical brand is not the bread and butter of this company (certainly not saying it won't eventually be a big hit but still early days with such a new product line in a space that's getting quickly crowded with very big players).  It's the medical distribution platform they are setting up - that is the key. Their goal is to build it out and get it right in Colombia and then drag and drop this knowledge and expertise as other Lat Am countries come online. Does that require a lot of capital outlay? hell yes it does because its all about having feet on the ground in Mexico, Brazil, etc with execs and attorneys making partnerships, keying in on M&A targets and staying abreast of and helping to steer regulatory policy, etc. within the burgeoning marketplace.

But I will say as all the mj stocks keep deflating here and valuations violently contract, it has continued to look more and more ugly and I'm certainly not ruling out the possibility that the 1.05 - 1.10 support zone gets tested. The chart is completely broken and 1 of 2 things needs to happen to turn things around imo. Either the sector has a violent oversold rally after this disastrous summer or Mexico announces legalization in Q4. Either of these possibilities could enable khrn to have a fast and furious rally toward the 2.50ish resistance line but for now, unfortunately, the path of least resistance continues to be down imo
Bullboard Posts